These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36601478)

  • 1. Low expression of H3K27me3 is associated with poor prognosis in conventional chordoma.
    Wei J; Wu J; Yin Z; Li X; Liu Y; Wang Y; Wang Z; Xu C; Fan L
    Front Oncol; 2022; 12():1048482. PubMed ID: 36601478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull base.
    Makise N; Shimoi T; Sunami K; Aoyagi Y; Kobayashi H; Tanaka S; Kawai A; Yonemori K; Ushiku T; Yoshida A
    Histopathology; 2023 Feb; 82(3):420-430. PubMed ID: 36217885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma.
    Zhang L; Guo S; Schwab JH; Nielsen GP; Choy E; Ye S; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    PLoS One; 2013; 8(9):e75851. PubMed ID: 24086644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis.
    Chen K; Mo J; Zhou M; Wang G; Wu G; Chen H; Zhang K; Yang H
    Med Oncol; 2014 Apr; 31(4):886. PubMed ID: 24535608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.
    Meng T; Yin H; Li B; Li Z; Xu W; Zhou W; Cheng M; Wang J; Zhou L; Yang X; Liu T; Yan W; Song D; Xiao J
    Neuro Oncol; 2015 May; 17(5):725-32. PubMed ID: 25488908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis.
    Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A
    Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.
    Zou MX; Huang W; Wang XB; Lv GH; Li J; Deng YW
    Int J Clin Exp Pathol; 2014; 7(8):4877-85. PubMed ID: 25197358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma.
    Jung M; Kim SI; Lim KY; Bae J; Park CK; Choi SH; Park SH; Won JK
    Hum Pathol; 2021 Sep; 115():96-103. PubMed ID: 34186055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study.
    Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z
    Front Oncol; 2020; 10():596330. PubMed ID: 33282745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression.
    Oh EJ; Yang WI; Cheong JW; Choi SE; Yoon SO
    Hum Pathol; 2014 Oct; 45(10):2043-50. PubMed ID: 25149548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis.
    Zou MX; Lv GH; Li J; She XL; Jiang Y
    Am J Transl Res; 2016; 8(2):516-29. PubMed ID: 27158344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis.
    Chen H; Zhang K; Wu G; Song D; Chen K; Yang H
    Int J Clin Exp Pathol; 2015; 8(11):14741-8. PubMed ID: 26823799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.
    Behling F; Fodi C; Gepfner-Tuma I; Kaltenbach K; Renovanz M; Paulsen F; Skardelly M; Honegger J; Tatagiba M; ; Schittenhelm J; Tabatabai G
    Neuro Oncol; 2021 Aug; 23(8):1273-1281. PubMed ID: 33367841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
    Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
    Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.
    Gokaslan ZL; Zadnik PL; Sciubba DM; Germscheid N; Goodwin CR; Wolinsky JP; Bettegowda C; Groves ML; Luzzati A; Rhines LD; Fisher CG; Varga PP; Dekutoski MB; Clarke MJ; Fehlings MG; Quraishi NA; Chou D; Reynolds JJ; Williams RP; Kawahara N; Boriani S
    J Neurosurg Spine; 2016 Apr; 24(4):644-51. PubMed ID: 26682601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chordomas of the skull base: follow-up review and prognostic factors.
    Colli BO; Al-Mefty O
    Neurosurg Focus; 2001 Mar; 10(3):E1. PubMed ID: 16734401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chordomas of the craniocervical junction: follow-up review and prognostic factors.
    Colli B; Al-Mefty O
    J Neurosurg; 2001 Dec; 95(6):933-43. PubMed ID: 11765837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and Prognostic Significance of H3K27 Trimethylation Protein in DLBCL].
    Deng YJ; Chen G; Zhu WF; Rui HB; Hong HL; Chen JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1379-1385. PubMed ID: 27784361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics Analysis Identified ASNS as a Novel Biomarker for Predicting Recurrence of Skull Base Chordoma.
    Shen Y; Li M; Xiong Y; Gui S; Bai J; Zhang Y; Li C
    Front Oncol; 2021; 11():698497. PubMed ID: 34540668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.